CRISPR patent “case of the year” hearing is a must-watch – and not just for the life sciences
Register to access two of our subscriber only articles per month.
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Author | Life sciences reporter
@IAM_magazine Research into the microbiome is producing revolutionary developments in our understanding of health and disease. In… https://t.co/XYCanV3uv3 Read more
@IAM_magazine IP Bridge has gone fully private in a management-led buyout, ending Japanese government involvement in the patent f… https://t.co/Cu7ZXlc3YD Read more
@IAM_magazine RT @WTRmagazine: As a generation of lawyers and support staff acclimatise to conducting their business from home, WTR spoke to two lawyers… Read more
@IAM_magazine RT @uspto: Just announced – the USPTO will use provisions of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) to extend t… Read more